Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian G Wicha

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2022
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, NigeriaMirjam Groger, Peter Akhideno, Christine J Kleist, et al.
Nature Medicine|May 15, 2026
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trialCyril Erameh, Kevin Okwaraeke, Christine Kleist, et al.
The Journal of Infection|February 4, 2023
Pretomanid-resistant tuberculosisNiklas Koehler, Sönke Andres, Matthias Merker, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2026
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIVLinda Stöger, Johannes Mischlinger, Tacilta Nhampossa, et al.
The Lancet. Microbe|January 30, 2026
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and GhanaJean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Pharmacological Research|January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacyLaura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2022
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, NigeriaMirjam Groger, Peter Akhideno, Christine J Kleist, et al.
Nature Medicine|May 15, 2026
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trialCyril Erameh, Kevin Okwaraeke, Christine Kleist, et al.
The Journal of Infection|February 4, 2023
Pretomanid-resistant tuberculosisNiklas Koehler, Sönke Andres, Matthias Merker, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2026
Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIVLinda Stöger, Johannes Mischlinger, Tacilta Nhampossa, et al.
The Lancet. Microbe|January 30, 2026
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and GhanaJean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, et al.
Pageof 12